Epstein–Barr Virus Common and Rare complications in Iraq: Review Paper

Authors

• Ameer Mohammed Kadhim, College of Medicine / University of Alkafeel / Najaf/IraqFollow
• M. Jafar Zainaldeen, College of Medicine / University of Alkafeel / Najaf/IraqFollow
• Zainab Haider Abdulmajeed, Najaf Directory of Health & Department of Microbiology, Faculty of Medicine University of Kufa, Najaf, IraqFollow

Abstract

Background: Epstein–Barr Virus (EBV) is a highly ubiquitous herpesvirus found globally, it is associated to both a wide range of condition including common, pervasive infections and severe, rare diseases. In Iraq, despite a significant increased incident of chronic illnesses and viral- related malignancies, the local overview of EBV-associated complications remains fragmented. Aim: This review synthesizes the current available Iraqi literature to delineate the dual nature of EBV’s impact, distinguishing between common epidemiological manifestations and its role in severe clinical complications in local cohorts. Key Findings: high seroprevalence (~80%) of EBV in healthy Iraqi population, with noteworthy association observed in autoimmune diseases including Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease (IBD). Severe complications included a DNA viremia in renal transplant and chronic kidney disease cohorts with about (33-36 %), and regional cancer patterns such as nasopharyngeal carcinoma in Anbar (west of Iraq) and Burkitt’s lymphoma in Kurdistan (north of Iraq),the prevalence is almost similar to the reported data from the neighboring regions. Conclusion: EBV in Iraq presents a dual public health challenge, encompassing both a common endemic presence and the risk of rare but severe, life-threatening complications, particularly in immunocompromised patients. These distinct patterns necessitate targeted surveillance and stratified clinical interventions.

Recommended Citation

Kadhim, Ameer Mohammed; Zainaldeen, M. Jafar; and Abdulmajeed, Zainab Haider (2026) "Epstein–Barr Virus Common and Rare complications in Iraq: Review Paper," Maaen Journal for Medical Sciences: Vol. 5 : Iss. 2 , Article 4.
Available at: https://doi.org/10.55810/2789-9136.1097

References

[1] Shechter O, Sausen DG, Gallo ES, Dahari H, Borenstein R. Epstein-Barr virus (EBV) epithelial associated malignancies: exploring pathologies and current treatments. Int J Mol Sci 2022;23(22).

[2] Chakravorty S, Afzali B, Kazemian M. EBV-associated diseases: current therapeutics and emerging technologies. Front Immunol 2022;13:1059133.

[3] Abbass R, Rasoul L. Investigating epstein-barr virus IgG antibodies as a biomarker for oncogenesis and immune evasion in lung cancer among Iraqi PatientsInvestigating Epstein-Barr Virus IgG antibodies as a biomarker for oncogenesis and immune evasion in lung cancer among Iraqi patients. J Fac Med Baghdad 2025;67:225—31.

[4] Soldan SS, Lieberman PM. Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 2023;21(1):51—64.

[5] Abdullahabbas A, Saadoon I. Relation of Epstein Barr virus with Interleukin-6 level among women with breast cancer in Ramadi City. Med Leg Update 2020;20:1393—8.

[6] Ghazi HF, Alubaidi GT, Fahad HM. SERO-PREVALENCE of epstein-barr virus in IRAQI inflammatory bowel disease. Wiad Lek 2022;75(8 pt 2):1979—84.

[7] Salih HH, Abd SY, Al-Kaseer E, Al-Diwan J. Cancer in Iraq, general view of annual report 2022. J Contemp Med Sci 2024;10(6).

[8] Muhealdeen DN, Shwan A, Yaqo RT, Hassan HA, Muhammed BO, Ali RM, et al. Epstein-Barr virus and Burkitt's lymphoma. Associations in Iraqi Kurdistan and twentytwo countries assessed in the International Incidence of Childhood cancer. Infect Agents Cancer 2022;17(1):39.

[9] Redha A, Al-Obaidi A, Kadhim H, Ghazi H. Sero-prevalence and plasma viral load of epstein barr virus among Iraqi blood donors. Iraqi JMS 2017;15:135—42.

[10] Sharifipour S, Davoodi Rad K. Seroprevalence of epsteinbarr virus among children and adults in Tehran, Iran. New Microbes New Infect 2020;34:100641.

[11] Ozkan A, Kilic SS, Kalkan A, Ozden M, Demirdag K, Ozdarendeli A. Seropositivity of epstein-barr virus in eastern anatolian region of Turkey. Asian Pac J Allergy Immunol 2003;21(1):49—53.

[12] Çetin Duran A, Ati T. Investigation of epstein-barr virus antibodies by chemiluminescent microparticle immunoassay method in patients of different age groups: evaluation of atypical serological profiles. Klimik Dergisi/Klimik J 2021; 34:1—6.

[13] Kofahi HM, Swedan JF, Aljezawi M. Correction: cytomegalovirus and epstein-barr virus infections among Jordanians: seroprevalence and associated factors. BMC Infect Dis 2025; 25(1):810.

[14] Talib Al-Nafakh R, Aldawmy F, Mubark H, Alfadhul S, Abdulrazzaq H, Almealawy Y, et al. Epstein—barr virus and rheumatoid arthritis in cancer patients undergoing chemotherapy. J Comm Dis 2023;55:119—25.

[15] Ad'hiah A, Atiyah N, Fadhil H. Qualitative and quantitative molecular analysis of epstein-barr virus in Iraqi patients with relapsing-remitting multiple sclerosis. Iraqi J Sci 2023: 127—37.

[16] Shams-Aldein S, Abdlameer A, Al-Obaidi A, Kadhim H, AlSaedi A. Detection of epstein barr virus in renal transplant recipients: two centers study. Iraqi Journal Of Medical Sciences 2015;13:191—9.

[17] Current insights into epstein - barr virus prevalence and clinical impact among kidney transplant recipients in Iraq: an updated review. Yemeni Journal for Medical Sciences 2025;19(11).

[18] Ihsan E, Mohammed L, Ali W, Yawoz M. Prevalence of Epstein-Barr Virus Among Hemodialysis Patients in Kirkuk City Article Informations Eman Ammar Ihsan. 2023.

[19] Taher N, Al-Obaidi A, Hussein R, Kadhim H. The possible role of torque teno virus in kidney allograft recipients in a sample of Iraqi patients. The Iraqi Journal of Medical Sciences 2021;18.

[20] Basem Z, Jameel H. Detection of epstein-barr virus among chronic kidney disease patients in Najaf, Iraq. Curr Issues Pharm Med Sci 2024;37:47—51.

[21] Ihsan EA, Mohammed LM, Ali WM. Prevalence of epsteinbarr virus among hemodialysis patients in Kirkuk city. NTU Journal of Pure Sciences 2023;2(4):17—22.

[22] Hamad HN. Serological detection of epstein-barr virus among hashimoto's thyroiditis patients in thi-qar province. Thi-Qar Medical Journal (TQMJ) 2025;27(1):202.

[23] Muhealdeen DN, Shwan A, Yaqo RT, Hassan HA, Muhammed BO, Ali RM, et al. Epstein-barr virus and Burkitt's lymphoma. Associations in Iraqi Kurdistan and twentytwo countries assessed in the international incidence of childhood cancer. Infect Agents Cancer 2022;17(1):39.

[24] Alani K. Detection of Epstein Barr Virus in Some Iraqi Women Patients with Invasive Ductal Carcinoma Using Immunohistochemistry Technique, 2021.

[25] Association of Epstein- Barr. Virus (EBV) with the development of nasopharyngeal carcinoma (NPC) in Western region of Iraq: unmatched molecular case-control study. Indian J Forensic Med Toxicol 2020;14(2):439—45.

[26] Washil A, Ozkan € O, € Jumaa M. Detection of epstein-barr virus (EBV) in women with breast cancer in Iraq using insitu hybridization and immunohistochemical techniques. J Med Lab Sci 2025;7:103—13.

[27] Nouri M, Larizadeh MH, Mollaei HR, Mianroodi AA, Bahador M, Shamsi S. Assessment of epstein-barr virus in patients with squamous cell carcinoma of the larynx by real-time polymerase chain reaction. J Contemp Med Sci 2021;7(6).

[28] Mahmood TA, Abbas HH, Yasir SJ. Epstein—barr virus infection related to low white blood cell count in cancer patients receiving chemotherapy in Al-Najaf governorate/ Iraq. J Pure Appl Microbiol 2020;14(2):1609—17.